Gilead's Kite Pharma unit nabs Marincola to head up its cell therapy research
Jan 19, 2021 - FierceBiotech
Board and Executive Moves
AbbVie and National Institutes of Health veteran Francesco Marincola, M.D., will become Gilead's new head of cell therapy research out of its Kite unit.
AbbVie and National Institutes of Health (NIH) veteran Francesco Marincola, M.D., will become Gilead's new head of cell therapy research out of its Kite unit.
He replaces Peter Emtage, Ph.D., who quit the company a few months back for a foray into venture capital work at Versant.
Marincola's official role as senior vice pres...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
